Frost Radar™: Global Full Product Development CMO in the IVD Industry, 2020

Frost Radar™: Global Full Product Development CMO in the IVD Industry, 2020

A Benchmarking System to Spark Companies to Action—Innovation That Fuels New Deal Flow and Growth Pipelines

RELEASE DATE
03-Nov-2020
REGION
North America
Research Code: PB10-01-00-00-00
SKU: HC03348-GL-MR_24857
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC03348-GL-MR_24857

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

Full product development IVD CMO comprises companies that partner with OEMs and support them in the development of IVD devices, ranging from concept to commercialization. IVD companies are continuously looking at new ways to optimize resources due to rising cost pressures and regulatory complexities, prompting industry participants to adopt innovative, integrated business models. CMOs are positioning themselves as one-stop-shop solution providers as opposed to the traditional functional service provider model, creating a mutually beneficial symbiotic relationship between OEMs and CMOs in the IVD industry. The IVD contract manufacturing market is highly fragmented, and witnessed a growth rate of 8.5% in 2019. Frost & Sullivan expects this segment to change significantly over the next few years since the majority of large IVD OEMs are focused on assay development, which is facing competition and capacity constraints due to stringent quality and regulatory requirements, strict delivery timelines, the need for good manufacturing practices, and delivery scale. OEMs are also increasingly outsourcing the design and manufacturing of instruments that perform diagnostics tests, heightening the competition among IVD CMOs to provide holistic services.

OEMs face challenges in meeting the rising demand for assays, reagents, and kits for COVID-19 testing, in turn, placing pressure on CMOs to scale up production of automated instruments with high throughput. The key strategic imperative for IVD instrument CMOs is to develop capabilities to manufacture simple, rapid, miniature, easy to use, automated, decentralized, and connected next-generation IVD devices with higher throughput rates to meet the ever-rising test demand. This is expected to boost competition among IVD CMOs to provide holistic services and become strategic partners to OEMs.

The Frost Radar™ reveals the market positioning of companies in an industry using their Growth and Innovation scores, as highlighted in the Frost Radar™ methodology. The document presents competitive profiles on each of the companies in the Frost Radar™ based on their strengths, opportunities, and a small discussion on their positioning. Frost & Sullivan analyzes hundreds of companies in the industry and benchmarks them across 10 criteria on the Frost Radar™, where the leading companies in the industry are then positioned. Industry leaders on both the Growth and Innovation indices are recognized as best practice recipients.

Author: Surbhi Gupta

Table of Contents

Strategic Imperative

Strategic Imperative (continued)

Growth Environment

Growth Environment (continued)

Frost Radar™: Global Full Product Development CMO in the IVD Industry

Frost Radar™: Competitive Environment

Frost Radar™: Competitive Environment (continued)

Frost Radar™: Competitive Environment (continued)

BIT Analytical Instruments GmbH

Cambridge Consultants

EKF Diagnostics

Hitachi High-Technologies Co., Ltd.

Invetech

KMC Systems

Nova Biomedical

Phillips-Medisize

Plexus Corporation

Stratec SE

Tecan

Ximedica

Strategic Insights

Significance of Being on the Frost Radar™

Frost Radar™ Empowers the CEO’S Growth Team

Frost Radar™ Empowers Investors

Frost Radar™ Empowers Customers

Frost Radar™ Empowers the Board of Directors

Frost Radar™: Benchmarking Future Growth Potential

Frost Radar™: Benchmarking Future Growth Potential

Legal Disclaimer

Full product development IVD CMO comprises companies that partner with OEMs and support them in the development of IVD devices, ranging from concept to commercialization. IVD companies are continuously looking at new ways to optimize resources due to rising cost pressures and regulatory complexities, prompting industry participants to adopt innovative, integrated business models. CMOs are positioning themselves as one-stop-shop solution providers as opposed to the traditional functional service provider model, creating a mutually beneficial symbiotic relationship between OEMs and CMOs in the IVD industry. The IVD contract manufacturing market is highly fragmented, and witnessed a growth rate of 8.5% in 2019. Frost & Sullivan expects this segment to change significantly over the next few years since the majority of large IVD OEMs are focused on assay development, which is facing competition and capacity constraints due to stringent quality and regulatory requirements, strict delivery timelines, the need for good manufacturing practices, and delivery scale. OEMs are also increasingly outsourcing the design and manufacturing of instruments that perform diagnostics tests, heightening the competition among IVD CMOs to provide holistic services. OEMs face challenges in meeting the rising demand for assays, reagents, and kits for COVID-19 testing, in turn, placing pressure on CMOs to scale up production of automated instruments with high throughput. The key strategic imperative for IVD instrument CMOs is to develop capabilities to manufacture simple, rapid, miniature, easy to use, automated, decentralized, and connected next-generation IVD devices with higher throughput rates to meet the ever-rising test demand. This is expected to boost competition among IVD CMOs to provide holistic services and become strategic partners to OEMs. The Frost Radar™ reveals the market positioning of companies in an industry using their Growth and Innovation scores, as highlighted in the Frost Radar™ methodology. The document presents competitive profiles on each of the companies in the Frost Radar™ based on their strengths, opportunities, and a small discussion on their positioning. Frost & Sullivan analyzes hundreds of companies in the industry and benchmarks them across 10 criteria on the Frost Radar™, where the leading companies in the industry are then positioned. Industry leaders on both the Growth and Innovation indices are recognized as best practice recipients. Author: Surbhi Gupta
More Information
No Index No
Podcast No
Author Surbhi Gupta
Industries Healthcare
WIP Number PB10-01-00-00-00
Is Prebook No
GPS Codes 9600-B1,9825-B1,9A06-B1,9562-B1,9571-B1,9573-B1,99BF-B1,99C0-B1,99C1-B1,99C6-B1,99C9-B1,99CB-B1,9568-B1,9611-B1,9627-B1